TY - JOUR
KW - Adolescent
KW - Buprenorphine/therapeutic use
KW - Cohort Studies
KW - Female
KW - Humans
KW - Male
KW - Naltrexone/therapeutic use
KW - Opiate Substitution Treatment/trends
KW - Opioid-Related Disorders/drug therapy
KW - Patient Acceptance of Health Care/statistics & numerical data
KW - Prevalence
KW - Retrospective Studies
KW - United States/epidemiology
KW - Young Adult
AU - S. E. Hadland
AU - J. F. Wharam
AU - M. A. Schuster
AU - F. Zhang
AU - J. H. Samet
AU - M. R. Larochelle
A1 - 
BT - JAMA pediatrics
C5 - Opioids & Substance Use
CP - 8
CY - United States
DO - 10.1001/jamapediatrics.2017.0745
IS - 8
JF - JAMA pediatrics
PP - United States
PY - 2017
SN - 2168-6211; 2168-6203
SP - 747
EP - 755
EP - 
T1 - Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014
T2 - JAMA pediatrics
TI - Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014
U1 - Opioids & Substance Use
U2 - 28628701
U3 - 10.1001/jamapediatrics.2017.0745
VL - 171
VO - 2168-6211; 2168-6203
Y1 - 2017
ER -